Cause of death, by non-communicable diseases, ages 0-4, male in Namibia
Namibia: Cause of death, by non-communicable diseases, ages 0-4, male was 11.6% in 2021. ▲ Rising
Cause of death, by non-communicable diseases, ages 0-4, male in Namibia, 2000–2021
Source: Global Health Estimates, World Health Organization (WHO). Measured in % of total male deaths ages 0-4.
Analysis
In 2021, cause of death, by non-communicable diseases, ages 0-4, male in Namibia stood at 11.6%.
Compared with earlier readings it is down 1.1% on the previous year and up 17.5% over ten years.
Over the whole period, cause of death, by non-communicable diseases, ages 0-4, male in Namibia peaked at 11.7% in 2020 and was at its lowest, 5.6%, in 2000.
Namibia ranks 142nd of 185 countries on this measure, in the bottom quarter.
Cause of death, by non-communicable diseases, ages 0-4, male in Namibia, year by year
| Year | % of total male deaths ages 0-4 | Change |
|---|---|---|
| 2000 | 5.6% | — |
| 2010 | 9.8% | +74.2% |
| 2015 | 9.6% | -2.2% |
| 2019 | 10.8% | +11.8% |
| 2020 | 11.7% | +8.6% |
| 2021 | 11.6% | -1.1% |
Namibia compared with similar countries
- Namibia's 11.6% is below the median for lower middle income countries, which is 12.2%, 94% of the median. (47 countries reporting)
- Namibia's 11.6% is above the median for Sub-Saharan Africa, which is 8.4%, 1.4× the median. (48 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 5.6% | 5.6% | 5.6% | 1 |
| 2010s | 10.1% | 9.6% | 10.8% | 3 |
| 2020s | 11.6% | 11.6% | 11.7% | 2 |
Countries ranked near Namibia
More health data for Namibia
- Un projection of annual infant deaths, annual growth rate -1.75 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.6445 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,046 deaths per 1,000 people (2090)
- Number of infants who die before age 1 561 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 1 (2024)
- Population ages 00-04, female, annual growth rate -1.83 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0644 units per person (2025)
- Population ages 00-04, male, annual growth rate -1.56 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is cause of death, by non-communicable diseases, ages 0-4, male in Namibia?
- Cause of death, by non-communicable diseases, ages 0-4, male in Namibia was 11.6% in 2021, according to Global Health Estimates, World Health Organization (WHO).
- What is the highest cause of death, by non-communicable diseases, ages 0-4, male recorded in Namibia?
- The highest recorded value was 11.7% in 2020.
- What is the lowest cause of death, by non-communicable diseases, ages 0-4, male recorded in Namibia?
- The lowest recorded value was 5.6% in 2000.
- How does Namibia rank for cause of death, by non-communicable diseases, ages 0-4, male?
- Namibia ranks 142nd out of 185 countries with data for 2021.
- Is cause of death, by non-communicable diseases, ages 0-4, male rising or falling in Namibia?
- Over the last ten years it is up 17.5%. The long-run trend across the full record is rising.
- Where does this Namibia data come from?
- The figures come from Global Health Estimates, World Health Organization (WHO), published as part of Cause of death, by non-communicable diseases, ages 0-4, male (% of total male deaths ages 0-4). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Number of male deaths ages 0-4 due to non-communicable diseases divided by number of all male deaths ages 0-4, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.